Clinical Trial

NAD Supplementation to Reduce the Incidence of Cardiac Surgery Associated Acute Kidney Injury

Name: NAD Supplementation to Reduce the Incidence of Cardiac Surgery Associated Acute Kidney Injury — clinical trial record (NCT07739290)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

The purpose of this single-center, randomized, double-blinded placebo-controlled pilot trial is to demonstrate feasibility and help design a larger trial to assess the effectiveness of nicotinamide (NAM) supplementation in reducing risk of post-operative AKI in patients undergoing cardiac surgery.

Trial Details

NCT Number	NCT07739290
Lead Sponsor	Beth Israel Deaconess Medical Center
Conditions	Acute Kidney Injury
Enrollment	20 participants
Start Date	2026-09-01
Primary Completion	2028-10-01 (estimated)
Study Completion	2029-01-01 (estimated)
Updated on ClinicalTrials.gov	2026-07-31